Filing Details

Accession Number:
0001179110-20-003507
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-12 07:34:57
Reporting Period:
2020-03-11
Accepted Time:
2020-03-12 07:34:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434868 Esperion Therapeutics Inc. ESPR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242613 M Timothy Mayleben C/O Esperion Therapeutics, Inc.
3891 Ranchero Drive, Suite 150
Ann Arbor MI 48108
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-11 2,500 $43.00 111,998 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct